Blood Pressure

New research shows nearly everyone can lower their blood pressure, even people currently on blood pressure- reducing drugs, by lowering their sodium intake. Read More

Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney. Read More

Enroll now in Health Plus' Control is the Goal blood pressure management program. Read More

Vanderbilt researchers have found that children with a genetic makeup that predicts high blood pressure as adults are more likely to survive congenital heart defect repair surgery. Read More

New cohorts of Control is the Goal begin quarterly (February, May, August and November). You will receive an email when the first module is available. The blood pressure management program is sponsored by Health Plus. Read More

As a participant in Control is the Goal, you will receive a weekly online module for six weeks. Read More

Heat therapy could offer a novel nonpharmacologic approach for treating the overnight hypertension that affects patients with autonomic failure. Read More

Racial disparities in hypertension risk are due in part to genetic differences between ancestries, Vanderbilt investigators find in a study of participants in the Million Veteran Program. Read More

As a participant in Control is the Goal, you will receive a weekly online six-week module. Learn more and enroll now. Read More

Excess dietary salt activates immune cells to induce inflammation and hypertension, supporting current recommendations for low sodium consumption. Read More

Consumption of soy foods may shape the microbiome and protect against hypertension only in individuals with soy-responsive microbiota, Vanderbilt researchers have discovered. Read More

Vanderbilt researchers have discovered that a protein called SGK1 in immune cells is activated by sodium, leading to the development of salt-sensitive hypertension. Read More

Vanderbilt researchers have identified a pathway that links excess sodium, inflammation and hypertension. Read More

Meena Madhur, M.D., Ph.D., assistant professor of Medicine, has received an NIH New Innovator Award, which is designed to support exceptionally creative, early-career investigators who propose innovative, high-impact projects. Read More

Faculty and staff can now check blood pressure and weight with Higi machines, which make staying on top of your health numbers convenient, simple, fun and rewarding. Read More

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older. Read More

Changes in the kidney can limit the blood pressure-lowering effects of thiazide diuretics, a new study reports. Read More

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease. Read More

Clinical pharmacologist Jens Titze, M.D., and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure. Read More

Clinical pharmacologist Jens Titze, M.D., and colleagues have discovered that – in contrast to the prevailing dogma – human sodium levels fluctuate rhythmically with 7-day and monthly cycles. Read More